ArticleCureus2025
Multiple Occult Fractures at Hemodialysis Initiation in a Chronic Kidney Disease Patient: Diagnostic Value of MRI and Potential Role of Zinc Deficiency.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We report the case of a 55-year-old man with end-stage kidney disease (ESKD) who developed multiple occult fractures within two months of hemodialysis initiation. Magnetic resonance imaging (MRI), but not radiography or computed tomography (CT), identified fractures in the calcanei, metatarsals, and pelvis. Laboratory findings revealed secondary hyperparathyroidism and hypozincemia. Treatment with calcimimetics, active vitamin D analogues, and zinc supplementation led to symptom resolution over 17 months. This case emphasizes the value of early MRI for unexplained pain at dialysis initiation and suggests that zinc deficiency may contribute to fracture risk in chronic kidney disease-mineral and bone disorder (CKD-MBD).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.